Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based studyMelina Arnold, Freddie Bray, Suzanne Leonfellner et al.|The Lancet Oncology|2019Cited by 1k
Towards the validation of a new, blended theoretical model of fear of cancer recurrenceSophie Lebel, Danielle Samara Tavares de Oliveira-Figueirêdo, Christine Maheu et al.|Psycho-Oncology|2018Cited by 80
Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancerChristine Maheu, Souraya Sidani, Sophie Lebel et al.|BMC Cancer|2016Cited by 59
Fear of cancer recurrence therapy (FORT): A randomized controlled trial.Christine Maheu, Rajvi J. Wani, Sophie Lebel et al.|Health Psychology|2023Cited by 40
Mechanisms of change of a cognitive-existential group intervention for fear of cancer recurrence: mediation analyses of the FORT trialSophie Lebel, Julia Parrott, Christine Maheu et al.|Journal of Psychosocial Oncology Research and Practice|2022Cited by 8